Vonka V, TARABCAK M, Janda Z
Arch Gesamte Virusforsch. 1964; 14:169-76.
PMID: 14141577
DOI: 10.1007/BF01555089.
Gelfand H, NAKANO J, Cole J
Public Health Rep (1896). 1962; 77:941-6.
PMID: 13947055
PMC: 1915166.
Takeda N, Sakae K, Agboatwalla M, Isomura S, Hondo R, Inouye S
J Clin Microbiol. 1994; 32(1):202-4.
PMID: 8126180
PMC: 262996.
DOI: 10.1128/jcm.32.1.202-204.1994.
HUMPHREY D, Kew O, Feorino P
Infect Immun. 1982; 36(2):841-3.
PMID: 6282759
PMC: 351306.
DOI: 10.1128/iai.36.2.841-843.1982.
Bull World Health Organ. 1981; 59(6):853-6.
PMID: 6279322
PMC: 2396132.
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus.
Kew O, Pallansch M, Omilianowski D, Rueckert R
J Virol. 1980; 33(1):256-63.
PMID: 6245231
PMC: 288542.
DOI: 10.1128/JVI.33.1.256-263.1980.
Poliovirus strain characterization: a WHO memorandum.
Bull World Health Organ. 1980; 58(5):727-30.
PMID: 6170471
PMC: 2395995.
Reduction in plaque size and reduction in plaque number as differing indices of influenza virus-antibody reactions.
Jahiel R, KILBOURNE E
J Bacteriol. 1966; 92(5):1521-34.
PMID: 5924276
PMC: 276453.
DOI: 10.1128/jb.92.5.1521-1534.1966.
Comparison of the immune response of the rabbit to virulent and attenuated strains of type 1 poliovirus.
Gaudin O, Viac J, Thouvenot D, SOHIER R
Bull World Health Organ. 1974; 50(6):479-5.
PMID: 4376464
PMC: 2481172.
Paralytic poliomyelitis in Ontario: laboratory studies of two recent cases.
SUBRAHMANYAN T, LESIAK J, Appleton F, LABZOFFSKY N
Bull World Health Organ. 1973; 49(3):245-50.
PMID: 4367777
PMC: 2481147.
Intracellular neutralization of poliovirus by type-specific antiserum.
BERENCSI G, Nagy G
Arch Gesamte Virusforsch. 1973; 43(4):320-5.
PMID: 4362932
DOI: 10.1007/BF01556148.
Differential sensitivity of virulent and attenuated strains of type 1 poliovirus to polyethylene glycol as a possible new genetic marker.
Lokteva V, CHUMAKOV M, ZHEVANDROVA V, SHEKOYAN L
Arch Gesamte Virusforsch. 1973; 41(3):155-9.
PMID: 4353792
DOI: 10.1007/BF01252759.
WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland.
Melnick J, BERENCSI G, Combiescu A, Furesz J, Kantoch M, KOSTRZEWSKI J
Bull World Health Organ. 1972; 47(3):287-94.
PMID: 4346582
PMC: 2480733.
Genetic marker studies of poliovirus. I. Natural variation.
Cossart Y
J Hyg (Lond). 1967; 65(1):67-76.
PMID: 4289679
PMC: 2130174.
DOI: 10.1017/s002217240004554x.
Control of a type 1 poliomyelitis epidemic in British Guiana, 1962-63, with trivalent oral poliovirus vaccine. 2. Virological aspects.
Feldman R, Mootoo C, Spence L, Gelfand H
Bull World Health Organ. 1965; 33(1):13-9.
PMID: 4284022
PMC: 2475822.
Poliomyelitis: epidemiology and prophylaxis. 4. Serological and virological surveys conducted after a mass vaccination campaign for the control of a threatening poliomyelitis epidemic.
METSELAAR D, McDonald K, GEMERT W, Nottay B, Muli J
Bull World Health Organ. 1977; 55(6):747-53.
PMID: 202417
PMC: 2366714.
